H1 FY26 Financial Results
| Stock | Visionflex Group Ltd (VFX.ASX) |
|---|---|
| Release Time | 26 Feb 2026, 5:49 p.m. |
| Price Sensitive | Yes |
Visionflex Group Ltd Reports H1 FY26 Financial Results
- H1 FY26 revenue of $1.7m, down 10% on prior period
- Recurring revenue up 29% to $0.9m, now 52% of total revenue
- Underlying EBITDA loss of $1.3m, consistent with prior period
Visionflex Group Limited, a leader in virtual healthcare solutions, has released its Appendix 4D and interim financial report for the 6 months ending 31 December 2025. The company reported H1 FY26 revenue of $1.7m, down 10% on the prior comparison period, reflecting the timing of enterprise contract execution. However, recurring revenue from subscriptions and support services increased 29% to $0.9m, now accounting for 52% of total revenue. Visionflex maintained cost discipline, with an Underlying EBITDA loss of $1.3m consistent with the prior period. The company strengthened its balance sheet, ending the half with a $1.1m cash balance and a further $1m of undrawn facilities available. Visionflex progressed enterprise deployments, including partnerships with Amplar Health for virtual nursing services in aged care and with Aspen Medical supporting Aboriginal Community Controlled Health Organisations. The company remains focused on increasing recurring revenue through expansion across residential aged care, regional/remote health, Indigenous health and government programs, building on existing enterprise relationships.
The company expects improved revenue performance in H2 FY26 as contracted deployments progress, with a focus on increasing recurring revenue through disciplined expansion across residential aged care, regional and remote health services, Indigenous health and government linked programs.